Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1991-08-30
1992-12-15
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424449, 424448, A61F 1300
Patent
active
051715767
ABSTRACT:
A method of preventing sensitization in transdermal drug delivery by the inclusion of a corticosteroid, which will be co-extensively coadministered with the sensitizing agent.
REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 4130643 (1978-12-01), Smith
patent: 4144317 (1979-03-01), Higuchi et al.
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4292303 (1981-09-01), Keith et al.
patent: 4314557 (1982-02-01), Chandrasekaran
patent: 4343798 (1982-08-01), Fawzi
patent: 4353896 (1982-10-01), Levy
patent: 4362737 (1982-12-01), Schafer et al.
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4548922 (1985-10-01), Carey et al.
patent: 4559222 (1985-12-01), Enscore et al.
patent: 4573995 (1986-03-01), Cheng et al.
patent: 4608249 (1986-08-01), Otsuka et al.
patent: 4634766 (1987-01-01), Atkinson et al.
patent: 4820720 (1989-04-01), Sanders et al.
patent: 4844902 (1989-07-01), Groke
patent: 4900555 (1990-02-01), Cheng et al.
patent: 4913905 (1990-04-01), Fankhauser et al.
patent: 5077054 (1991-12-01), Amkraut et al.
Drug Information 86, 84:06 "Anti-Inflammatory Agents: Topical Corticosteroids General Statement", pp. 1780-1782, American Hospital Formulary Service.
J. Foussereau, C. Benezra, H. I. Maibach & N. Hjorth, "Occupational Contact Dermatitis, Clinical and Chemical Aspects", (W. B. Saunders Company 1982).
B. W. Barry and D. I. D. El Eini, "Influence of Non-Ionic Surfactants on Permeability of Hydrocortisone, Dexamethasone, Testosterone and Progesterone Across Cellulose Acetate Membrane", J. Pharm. Pharmac. 28, pp. 219-227 (1976).
D. V. Belsito et al., "Effect of Glucocorticosteroids on Epidermal Langerhans Cells", J. Exp. Med., vol. 155, pp. 291-302.
W. M. Burrows et al., "Inhibition of Induction of Human Contact Sensitization by Topical Clucocorticosteroid", Arch Dermatol, vol. 112, pp. 175-178 (Feb. 1986).
B. Berman et al., "Modulation of Expression of Epidermal Langerhans Cell Properties Following in Situ Exposure to Glucocorticosteroids", The Journal of Investigative Dermatology, vol. 80, No. 3, pp. 168-171 (1983).
"Contact Dermatitis due to Nitrogylcerin Ointment", A. A. Hendricks and G. W. Dec Arch. Dermatol. 115: 853-855 (1979).
J. Fachet et al., "Effect of Corticosteroids and Adult Thymectomy on Induction and Recall of Contact Sensitivity in Mice", Clin. Exp. Immunol 10, pp. 661-692 (1972).
Geoffrey Zubay, Biochemistry, pp. 535-543 (1983).
B. Samuelsson, "Leubotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation", Science, vol. 220, pp. 568-575.
AMA Drug Evaluations, 5th Edition, pp. 1441-1442.
Amkraut Alfred
Shaw Jane E.
ALZA Corporation
Horne Leon R.
Mandell Edward L.
Miller D. Byron
Page Thurman K.
LandOfFree
Prevention of contact allergy by coadministration of a corticost does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of contact allergy by coadministration of a corticost, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of contact allergy by coadministration of a corticost will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2091499